| P50 | author | Hironori Nakagami | Q30505241 |
| | Hiromi Rakugi | Q35703947 |
| | Misa Hayashi | Q87800983 |
| | Eiji Kiyohara | Q87800987 |
| P2093 | author name string | Ken Sugimoto | |
| | Ayumi Nakamura | |
| | Ichiro Katayama | |
| | Minoru Takemoto | |
| | Tamotsu Ebihara | |
| | Koutaro Yokote | |
| | Hiroshi Ando | |
| | Takahiro Ishikawa | |
| | Yoichi Takami | |
| | Hideki Hanaoka | |
| | Masaya Koshizaka | |
| | Yasushi Takeya | |
| | Mitsunori Nishikawa | |
| | Taku Fujimoto | |
| | Koichi Yamamoto | |
| | Toshifumi Yamaoka | |
| | Yuta Terabe | |
| | Xiang Jing Yao | |
| P2860 | cites work | Defensins: antimicrobial peptides of innate immunity | Q28204453 |
| | The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes | Q28262941 |
| | Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway | Q28541612 |
| | Positional cloning of the Werner's syndrome gene | Q29618393 |
| | Development of a novel antimicrobial peptide, AG-30, with angiogenic properties | Q33328109 |
| | An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. | Q34534186 |
| | Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study | Q34747226 |
| | Bacteria and wound healing. | Q35691069 |
| | The health care costs of diabetic peripheral neuropathy in the US. | Q50719755 |
| | Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. | Q53459206 |
| | Premature aging gene discovered | Q71003760 |
| | PR39, a peptide regulator of angiogenesis | Q73308219 |
| | Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial | Q73435807 |
| | Reliability and validity of DESIGN, a tool that classifies pressure ulcer severity and monitors healing | Q76347597 |
| | Guidance for industry: chronic cutaneous ulcer and burn wounds-developing products for treatment | Q77068218 |
| | Chronic leg ulcers in Werner's syndrome | Q79363900 |
| | Topical PDGF-BB results in limited healing in a patient with Werner's syndrome and chronic leg ulcers | Q81087124 |
| | Emerging new drugs for wound repair | Q36407396 |
| | APD3: the antimicrobial peptide database as a tool for research and education | Q36434966 |
| | Peptide antimicrobial agents | Q36538861 |
| | Antimicrobial peptides: an essential component of the skin defensive barrier. | Q36566198 |
| | Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents | Q37295564 |
| | AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense | Q37393392 |
| | The FDA and designing clinical trials for chronic cutaneous ulcers | Q38051923 |
| | Physician-initiated first-in-human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers | Q40219195 |
| | Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates. | Q40585339 |
| | IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes | Q40991248 |
| | Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial | Q42672939 |
| | APD2: the updated antimicrobial peptide database and its application in peptide design | Q43122430 |
| | Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings | Q44053817 |
| | Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream | Q46260034 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 2 | |
| P577 | publication date | 2018-02-13 | |
| P1433 | published in | NPJ aging and mechanisms of disease | Q27727292 |
| P1476 | title | Physician-initiated clinical study of limb ulcers treated with a functional peptide, SR-0379: from discovery to a randomized, double-blind, placebo-controlled trial | |
| P478 | volume | 4 | |